Biocon Ltd’s share price fell 4.86 per cent on January 27, 2025, hitting a day’s low of Rs 369.40 on the NSE, while the NIFTY ...

Biocon share price rose 4.5% following US FDA clearance for its Malaysian insulin facility, resolving a regulatory bottleneck. Bank of America raised its price target by 9% to ₹435, reflecting ...

Biocon share price gained 2.61 per cent at Rs 398 a piece on the BSE in Thursday’s intraday trade. This came after the ...

According to reports, HSBC said that Biocon is well-placed for an operational turnaround, driven by key biosimilar launches ...

The firm raised its rating on Biocon to 'underperform' and increased its target price by 43% to Rs 400, citing positive developments around the regulatory approval of the company's manufacturing ...

With an increased confidence in the company’s prospects, HSBC raised its earnings estimates for Biocon, projecting ...

Biocon Ltd share price was up by 0.14% from the previous closing price of ₹393.15. Who are peers of Biocon Ltd? The peers of Biocon Ltd are Sun Pharmaceuticals Industries Ltd, Divis Laboratories ...

The stock has gained 9.66% in the last month, 7.99% over the past six months, and an impressive 37.98% in the last year.

HSBC expects an operational turnaround for Biocon, driven by major biosimilar launches and a rebound in generics sales. The brokerage sees several factors supporting future earnings growth, including ...

is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations for the trailing 12 month period. Earnings Per Share (TTM ...

Biocon share price surged 4.5% during Monday's session following the clearance from the US Food and Drug Administration (US FDA) for the insulin facility of Biocon Biologics in Malaysia.

Natural Biocon (India) Ltd share price was down by -1.23% from the previous closing price of ₹13.78. Who are peers of Natural Biocon (India) Ltd? The peers of Natural Biocon (India) Ltd are ...